TITLE

X-linked carrier status for glycogen storage disease type IX is protective in hemochromatosis

AUTHOR(S)
Wheeler, Seth; DeCross, Arthur J; Schiffhauer, Linda; Sundaram, Uma
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS211
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "X-linked Carrier Status for Glycogen Storage Disease Type IX is Protective in Hemochromatosis" by Seth Wheeler, Arthur J. DeCross, Linda Schiffhauer, and Uma Sundaram is presented.
ACCESSION #
66954872

 

Related Articles

  • Inherited metabolic disease of the liver.  // Current Medical Literature: Lysosomal Storage Disease;2008, Vol. 8 Issue 2, p62 

    The article reports on the result of the study which assesses iron, glycogen and copper metabolism in the diagnosis and treatment of inherited liver diseases. These diseases include Wilson disease, glycogen storage disease and genetic hemochromatosis. It was found that evaluating metabolic...

  • McArdle's disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1415 

    A definition of the medical term "McArdle's disease" which refers to a glycogen storage disease is presented.

  • Andersen's disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p114 

    A definition of the term "Andersen's disease," which refers to a type IV glycogen storage disease, is presented.

  • Lenograstim.  // Reactions Weekly;Mar2014, Vol. 1494 Issue 1, p33 

    An abstract of the article "Liver cirrhosis in glycogen storage disease Ib," by F. Baertling and colleagues is presented.

  • A juvenile case of type IV glycogenosis with cardiomyopathy.  // Canadian Journal of Neurological Sciences;May2003 Supplement 2, Vol. 30, pS44 

    Presents an abstract of the study 'A Juvenile Case of Type IV Glycogenosis With Cardiomyopathy' submitted to the 38th meeting of the Canadian Congress of Neurological Sciences.

  • Neutrophil adherence receptor deficiency regressing with granulocyte-colony stimulating factor therapy in a case of glycogen storage disease type 1b. Latger-Cannard, V é ronique; Marchand-Arvier, Monique; Vidailhet, Michel; Donadieu, Jean; Vigneron, Claude; Bordigoni, Pierre // European Journal of Pediatrics;2002, Vol. 161 Issue 2, p87 

    Describes a patient with glycogen storage disease type Ib (GSD-Ib) who presented with recurrent infections, diminished neutrophil functions and a neutrophil adherence receptor deficiency. Clinical characteristics of patients suffering from GSD-Ib; Cystometric evaluation of adherence receptors.

  • 912. Long-Term Efficacy of AAV Vector-Mediated Gene Therapy in the Mouse Model for Glycogen Storage Disease Type la (GSD-Ia) Koeberl, Dwight D.; Sun, Baodong; Damodaran, Tirupapuliyur; Brown, Talmage; Bird, Andrew; Schneider, Ayn; Millington, David S.; Chen, Y.-T. // Molecular Therapy;Jun2005, Vol. 11, p352 

    An abstract of the article "Long-Term Efficacy of AAV Vector-Mediated Gene Therapy in the Mouse Model for Glycogen Storage Disease Type la (GSD-Ia)," by Dwight D. Koeberl and colleagues is presented.

  • ERRATUM.  // Journal of Pediatric Endocrinology & Metabolism;Feb2009, Vol. 22 Issue 2, p191 

    A correction to the article "Glycogen Storage Disease Type IIIa Presenting as Non-Ketotic Hypoglycemia: Use of Newly Approved Commercially Available Mutation Analysis to Non-Invasively Confirm the Diagnosis," that was published in the Volume 22, No. 2, 2009 issue of the "Journal of Pediatric...

  • Pompe's disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1850 

    An encyclopedia entry for the term "Pompe's disease" which refers to a type II glycogen storage disease is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics